Azathioprine, Thermo Scientific Chemicals
Azathioprine, Thermo Scientific Chemicals
Thermo Scientific Chemicals

Azathioprine, Thermo Scientific Chemicals

Have Questions?
Change viewbuttonViewtableView
Quantity:
1 g
5 g
10 g
This chemical may require us to obtain additional information for our regulatory and chemical compliance records. If required, we will contact you for this information once your order is placed.
Catalog number J62314.03
also known as J62314-03
Price (USD)/ Each
118.00
-
Add to cart
Quantity:
1 g
Request bulk or custom format
Price (USD)/ Each
118.00
Add to cart
Azathioprine, Thermo Scientific Chemicals
Catalog numberJ62314.03
Price (USD)/ Each
118.00
-
Add to cart
Specifications
Chemical Name or MaterialAzathioprine
CAS446-86-6
Health Hazard 1H302-H315-H319-H335-H350
Health Hazard 2GHS H Statement
H350-H302-H315-H319-H335
May cause cancer.
Harmful if swallowed.
Causes skin irritation.
Causes serious eye irritation.
May cause respiratory irritation.
Health Hazard 3P201-P202-P261-P264b-P270-P271-P280i-P281-P301+P312-P302+P352-P304+P340-P305+P351+P338-P308+P313-P330-P332+P313-P362-P501c
View more
Azathioprine is an immunosuppressive purine antimetabolite. The mechanism of action of azathioprine is as a nucleic acid synthesis inhibitor. It has shown promise in treatment of alopecia areata (autoimmune hair loss), with no difference in effectiveness between genders.

This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.

Solubility
Soluble in Dichloromethane and dimethyl sulfoxide.

Notes
Store at -20°C. Incompatible with oxidizing agents. Protect from heat.
WARNING: Cancer and Reproductive Harm – www.P65Warnings.ca.gov
RUO – Research Use Only
W.R. Connell.; Kamm.; Ritchie.; Prof J.E. Lennard-Jones.; Dickson.; A.M. Balkwill. Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease.The Lancet. 1994, 343 (8908),1249-1252 .